ConductScience.org, home

Paper39670906

[Monoclonal Antibodies in Allergic Diseases: Development, Pharmacology, and Clinical Applications]

Pury S and 8 others. Rev Fac Cien Med Univ Nac Cordoba, 2024. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. [Monoclonal Antibodies in Allergic Diseases: Development, Pharmacology, and Clinical Applications]. Papers, record 39670906. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39670906

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
[Monoclonal Antibodies in Allergic Diseases: Development, Pharmacology, and Clinical Applications]
PubMed
Journal
Rev Fac Cien Med Univ Nac Cordoba
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review, English Abstract
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0.0, provisional
iCite
Revised in PubMed
2025-03-15
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pury SSelene
2Saranz RJRicardo José
3Irastorza MJMaría José
4Sasia LVLaura Veronica
5Visconti PPilar
6Alegre GGraciela
7Lozano NANatalia Andrea
8Berardi YVYanina Viviana
9Lozano AAlejandro

Source PubMed

Download CSV of authors

Topics4

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
HypersensitivityMajor topic
Humans
Animals

References49

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
13085297Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression.Transplantation1986https://conductscience.org/library/papers/3085297PubMed
28075633Antigen-specific human monoclonal antibodies from mice engineered with human Ig heavy and light chain YACs.Nat Genet1994https://conductscience.org/library/papers/8075633PubMed
333965091Roles of innate lymphoid cells (ILCs) in allergic diseases: The 10-year anniversary for ILC2s.J Allergy Clin Immunol2021https://conductscience.org/library/papers/33965091PubMed
437684154Current and Novel Biologic Therapies for Patients with Asthma and Nasal Polyps.Otolaryngol Clin North Am2024https://conductscience.org/library/papers/37684154PubMed
532494573The role of interleukin-17 in asthma: a protective response?ERJ Open Res2020https://conductscience.org/library/papers/32494573PubMed
636829616Bioengineering of Antibody Fragments: Challenges and Opportunities.Bioengineering (Basel)2023https://conductscience.org/library/papers/36829616PubMed
711880051Emil von Behring and serum therapy.Microbes Infect2002https://conductscience.org/library/papers/11880051PubMed
89048207Finally! The Brambell receptor (FcRB). Mediator of transmission of immunity and protection from catabolism for IgG.Immunol Res1997https://conductscience.org/library/papers/9048207PubMed
933923629Molecular Mechanisms of Atopic Dermatitis Pathogenesis.Int J Mol Sci2021https://conductscience.org/library/papers/33923629PubMed
1030206782Understanding Asthma Phenotypes, Endotypes, and Mechanisms of Disease.Clin Rev Allergy Immunol2019https://conductscience.org/library/papers/30206782PubMed
1131793004Concept of Pharmacologic Target-Mediated Drug Disposition in Large-Molecule and Small-Molecule Compounds.J Clin Pharmacol2020https://conductscience.org/library/papers/31793004PubMed
1237679612Antibody Phage Display.Methods Mol Biol2023https://conductscience.org/library/papers/37679612PubMed
1336669622Mechanisms underlying the efficacy and safety of IgG, antibody fragments, and design immune biologics.J Allergy Clin Immunol2023https://conductscience.org/library/papers/36669622PubMed
148159246Antigen-specific human antibodies from mice comprising four distinct genetic modifications.Nature1994https://conductscience.org/library/papers/8159246PubMed
1532586877Treatment options in type-2 low asthma.Eur Respir J2021https://conductscience.org/library/papers/32586877PubMed
1637240477Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis.J Clin Med2023https://conductscience.org/library/papers/37240477PubMed
1717636457Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice.J Pharmacokinet Pharmacodyn2007https://conductscience.org/library/papers/17636457PubMed
1836448493Chronic spontaneous urticaria: Focus on pathophysiology to unlock treatment advances.Allergy2023https://conductscience.org/library/papers/36448493PubMed
191172191Continuous cultures of fused cells secreting antibody of predefined specificity.Nature1975https://conductscience.org/library/papers/1172191PubMed
2024200404Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma.Am J Respir Crit Care Med2013https://conductscience.org/library/papers/24200404PubMed

See all 49 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39670906

GET https://conductscience.org/api/papers/v1/39670906/references?page=2